vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.
PROCORE TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($359.3M vs $208.9M, roughly 1.7× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -2.5%, a 5.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 15.7%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 12.4%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.
IRTC vs PCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $359.3M |
| Net Profit | $5.6M | $-9.1M |
| Gross Margin | 70.9% | 80.1% |
| Operating Margin | 1.1% | 15.5% |
| Net Margin | 2.7% | -2.5% |
| Revenue YoY | 27.1% | 15.7% |
| Net Profit YoY | 518.5% | 72.4% |
| EPS (diluted) | $0.18 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $359.3M | ||
| Q4 25 | $208.9M | $349.1M | ||
| Q3 25 | $192.9M | $338.9M | ||
| Q2 25 | $186.7M | $323.9M | ||
| Q1 25 | $158.7M | $310.6M | ||
| Q4 24 | $164.3M | $302.0M | ||
| Q3 24 | $147.5M | $295.9M | ||
| Q2 24 | $148.0M | $284.3M |
| Q1 26 | — | $-9.1M | ||
| Q4 25 | $5.6M | $-37.6M | ||
| Q3 25 | $-5.2M | $-9.1M | ||
| Q2 25 | $-14.2M | $-21.1M | ||
| Q1 25 | $-30.7M | $-33.0M | ||
| Q4 24 | $-1.3M | $-62.3M | ||
| Q3 24 | $-46.2M | $-26.4M | ||
| Q2 24 | $-20.1M | $-6.3M |
| Q1 26 | — | 80.1% | ||
| Q4 25 | 70.9% | 80.1% | ||
| Q3 25 | 71.1% | 79.7% | ||
| Q2 25 | 71.2% | 79.1% | ||
| Q1 25 | 68.8% | 79.1% | ||
| Q4 24 | 70.0% | 81.2% | ||
| Q3 24 | 68.8% | 81.4% | ||
| Q2 24 | 69.9% | 83.1% |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 1.1% | -12.3% | ||
| Q3 25 | -4.4% | -4.4% | ||
| Q2 25 | -10.0% | -9.3% | ||
| Q1 25 | -20.5% | -11.7% | ||
| Q4 24 | -2.5% | -21.9% | ||
| Q3 24 | -34.1% | -12.3% | ||
| Q2 24 | -15.5% | -5.2% |
| Q1 26 | — | -2.5% | ||
| Q4 25 | 2.7% | -10.8% | ||
| Q3 25 | -2.7% | -2.7% | ||
| Q2 25 | -7.6% | -6.5% | ||
| Q1 25 | -19.3% | -10.6% | ||
| Q4 24 | -0.8% | -20.6% | ||
| Q3 24 | -31.3% | -8.9% | ||
| Q2 24 | -13.6% | -2.2% |
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $0.18 | $-0.25 | ||
| Q3 25 | $-0.16 | $-0.06 | ||
| Q2 25 | $-0.44 | $-0.14 | ||
| Q1 25 | $-0.97 | $-0.22 | ||
| Q4 24 | $-0.03 | $-0.42 | ||
| Q3 24 | $-1.48 | $-0.18 | ||
| Q2 24 | $-0.65 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $386.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $1.2B |
| Total Assets | $1.0B | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $386.0M | ||
| Q4 25 | $583.8M | $768.5M | ||
| Q3 25 | $565.2M | $684.0M | ||
| Q2 25 | $545.5M | $620.9M | ||
| Q1 25 | $520.6M | $566.7M | ||
| Q4 24 | $535.6M | $775.4M | ||
| Q3 24 | $522.0M | $756.9M | ||
| Q2 24 | $561.5M | $735.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $152.7M | $1.3B | ||
| Q3 25 | $121.9M | $1.2B | ||
| Q2 25 | $103.7M | $1.2B | ||
| Q1 25 | $86.7M | $1.2B | ||
| Q4 24 | $90.9M | $1.3B | ||
| Q3 24 | $71.8M | $1.3B | ||
| Q2 24 | $99.2M | $1.3B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.0B | $2.2B | ||
| Q3 25 | $995.2M | $2.1B | ||
| Q2 25 | $964.0M | $2.0B | ||
| Q1 25 | $926.1M | $1.9B | ||
| Q4 24 | $931.4M | $2.1B | ||
| Q3 24 | $909.7M | $2.0B | ||
| Q2 24 | $919.2M | $2.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $76.8M |
| Free Cash FlowOCF − Capex | $14.5M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $76.8M | ||
| Q4 25 | $26.2M | $114.9M | ||
| Q3 25 | $34.9M | $88.5M | ||
| Q2 25 | $27.7M | $30.8M | ||
| Q1 25 | $-7.9M | $66.0M | ||
| Q4 24 | $19.2M | $29.1M | ||
| Q3 24 | $24.3M | $39.3M | ||
| Q2 24 | $11.8M | $58.7M |
| Q1 26 | — | — | ||
| Q4 25 | $14.5M | $109.2M | ||
| Q3 25 | $20.1M | $83.1M | ||
| Q2 25 | $17.3M | $27.9M | ||
| Q1 25 | $-17.3M | $62.0M | ||
| Q4 24 | $12.4M | $17.4M | ||
| Q3 24 | $15.5M | $35.7M | ||
| Q2 24 | $3.4M | $56.8M |
| Q1 26 | — | — | ||
| Q4 25 | 6.9% | 31.3% | ||
| Q3 25 | 10.4% | 24.5% | ||
| Q2 25 | 9.3% | 8.6% | ||
| Q1 25 | -10.9% | 20.0% | ||
| Q4 24 | 7.5% | 5.8% | ||
| Q3 24 | 10.5% | 12.1% | ||
| Q2 24 | 2.3% | 20.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 1.6% | ||
| Q3 25 | 7.7% | 1.6% | ||
| Q2 25 | 5.6% | 0.9% | ||
| Q1 25 | 5.9% | 1.3% | ||
| Q4 24 | 4.2% | 3.9% | ||
| Q3 24 | 6.0% | 1.2% | ||
| Q2 24 | 5.7% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PCOR
Segment breakdown not available.
